Skip to main content

Animations

MJFF Publications

4621 - 4630 of 8673 Results
Title
Year
  • Year
  • 2018
  • 2015
  • 2023
  • 2024
  • 2015
  • 2018
  • 2012
  • 2023
  • 2020
  • 2020
  • Summary Details
    OPEN
    Title: Neuromodulation targets pathological not physiological beta bursts during gait in Parkinson's disease
    Journal Name: Neurobiology of Disease
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.nbd.2018.09.004
    Best OA location URL:
    Citation Count: 125
  • Summary Details
    RESTRICTED
    Title: Impact of Parkinson's disease risk loci on age at onset
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1002/mds.26237
    Best OA location URL:
    Citation Count: 53
  • Summary Details
    OPEN
    Title: FLED: a full-length eccDNA detector for long-reads sequencing data
    Journal Name: Briefings in Bioinformatics
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1093/bib/bbad388
    Citation Count: 9
  • Summary Details
    OPEN
    Title: Comprehensive proteomics of CSF, plasma, and urine identify DDC and other biomarkers of early Parkinson’s disease
    Journal Name: Acta Neuropathologica
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1007/s00401-024-02706-0
    Citation Count: 41
  • Summary Details
    OPEN
    Title: Detecting and monitoring the symptoms of Parkinson's disease using smartphones: A pilot study
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2015.02.026
    Best OA location URL:
    Citation Count: 351
  • Summary Details
    OPEN
    Title: A Proposed Roadmap for Parkinson’s Disease Proof of Concept Clinical Trials Investigating Compounds Targeting Alpha-Synuclein
    Journal Name: Journal of Parkinson's Disease
    Publisher: SAGE Publications
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.3233/jpd-181471
    Citation Count: 52
  • Summary Details
    OPEN
    Title: Prolonged Maturation Culture Favors a Reduction in the Tumorigenicity and the Dopaminergic Function of Human ESC‐Derived Neural Cells in a Primate Model of Parkinson's Disease
    Journal Name: STEM CELLS
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/stem.1060
    Citation Count: 166
  • Summary Details
    OPEN
    Title: Developing better digital health measures of Parkinson’s disease using free living data and a crowdsourced data analysis challenge
    Journal Name: PLOS Digital Health
    Publisher: Public Library of Science (PLoS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1371/journal.pdig.0000208
    Citation Count: 5
  • Summary Details
    OPEN
    Title: Body-first versus brain-first biological subtyping of Parkinson’s disease
    Journal Name: Brain
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1093/brain/awaa293
    Citation Count: 21
  • Summary Details
    OPEN
    Title: The Alzheimer's disease‐associated C99 fragment of APP regulates cellular cholesterol trafficking
    Journal Name: The EMBO Journal
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.15252/embj.2019103791
    Citation Count: 107
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.